The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| DOC | -11.08% | -15.76% | -3.37% | +5,853% |
| S&P | +14.5% | +93.32% | +14.09% | +3,471% |
Healthpeak Properties, Inc. is a real estate investment trust, which engages in the acquisition, development, ownership, and management of healthcare real estate. It operates through the following business segments: Life Science, Medical Office and Continuing Care Retirement Community (CCRC). The Life Science segment contains laboratory and office space primarily for biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Medical Office segment includes medical office buildings and hospitals. The CCRC segment includes independent living, assisted living, and skilled nursing units to provide a continuum of care on a campus. The company was founded on March 21, 1985 and is headquartered in Denver, CO.
A list of high-yielding dividend stocks to consider buying now.
These two stocks are trading cheaply right now and can help you build wealth over the long term.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $694.35M | -0.2% |
| Gross Profit | $152.25M | 10.2% |
| Gross Margin | 21.93% | 2.1% |
| Market Cap | $12.16B | -11.8% |
| Market Cap / Employee | $31.43M | 0.0% |
| Employees | 387 | 100.5% |
| Net Income | $38.90M | -74.5% |
| EBITDA | $393.90M | -0.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $163.28M | 2.5% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $9.35B | 2.6% |
| Short Term Debt | $1.86M | -93.5% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 0.82% | -0.8% |
| Return On Invested Capital | 3.20% | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $345.83M | 19.7% |
| Operating Free Cash Flow | $371.56M | 14.4% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 48.66 | 58.41 | 50.96 | 74.61 | 76.85% |
| Price to Book | 1.83 | 1.66 | 1.68 | 1.50 | -3.68% |
| Price to Sales | 6.26 | 5.25 | 5.05 | 4.35 | -23.81% |
| Price to Tangible Book Value | 2.10 | 1.85 | 1.88 | 1.65 | -7.85% |
| Price to Free Cash Flow TTM | 93.67 | 77.54 | 55.44 | 39.15 | -55.86% |
| Enterprise Value to EBITDA | 64.38 | 59.90 | 58.54 | 55.90 | -5.63% |
| Free Cash Flow Yield | 1.1% | 1.3% | 1.8% | 2.6% | 126.55% |
| Return on Equity | 4.1% | 3.3% | 3.3% | 2.0% | -47.66% |
| Total Debt | $9.09B | $9.22B | $9.18B | $9.35B | 2.27% |
PEAK earnings call for the period ending September 30, 2021.
PEAK earnings call for the period ending June 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
